Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia [Corrigendum]
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details